12-50396397-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001145475.3(FAM186A):āc.88C>Gā(p.Gln30Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000129 in 1,551,454 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001145475.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FAM186A | NM_001145475.3 | c.88C>G | p.Gln30Glu | missense_variant | 1/8 | ENST00000327337.6 | NP_001138947.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FAM186A | ENST00000327337.6 | c.88C>G | p.Gln30Glu | missense_variant | 1/8 | 5 | NM_001145475.3 | ENSP00000329995.5 | ||
FAM186A | ENST00000543111.5 | c.88C>G | p.Gln30Glu | missense_variant | 1/8 | 5 | ENSP00000441337.1 | |||
LARP4 | ENST00000550522.5 | c.-193+3809G>C | intron_variant | 4 | ENSP00000448180.1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 31
GnomAD4 exome AF: 7.15e-7 AC: 1AN: 1399370Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 690188
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152084Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74288
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.88C>G (p.Q30E) alteration is located in exon 1 (coding exon 1) of the FAM186A gene. This alteration results from a C to G substitution at nucleotide position 88, causing the glutamine (Q) at amino acid position 30 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at